HPLC-UV method for the simultaneous determinations of ascorbic acid and dehydroascorbic acid in human plasma.
10.12793/tcp.2016.24.1.37
- Author:
Yunjeong KIM
1
;
Min Gul KIM
Author Information
1. Clinical Pharmacology Unit and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju 54907, Korea. mgkim@jbnu.ac.kr
- Publication Type:Original Article
- Keywords:
Ascorbic acid;
Dehydroascorbic acid;
Dithiothreitol;
HPLC;
Method validation
- MeSH:
Administration, Oral;
Ascorbic Acid*;
Chromatography, High Pressure Liquid;
Chromatography, Liquid;
Dehydroascorbic Acid*;
Dithiothreitol;
Humans*;
Plasma*;
Tablets;
Volunteers
- From:Translational and Clinical Pharmacology
2016;24(1):37-42
- CountryRepublic of Korea
- Language:English
-
Abstract:
A high performance liquid chromatography (HPLC) paired with UV-vis detection method to determine ascorbic acid and its oxidation product, dehydroascorbic acid, in human plasma was developed. Ascorbic acid in human plasma was extracted and stabilized using 10% metaphosphoric acid, and was analyzed by a Symmetry C18 column with 5 mM Hexadecyltrimethylammonium bromide and 50 mM KH2PO4 solution as the mobile phase (1.0 mL/min flow rate). Isoascorbic acid served as the internal standard and ultraviolet detector wavelength was 254 nm and 265 nm. Dehydroascorbic acid concentration was calculated from the differences in ascorbic acid concentration before and after reduction by dithiothreitol reagent. Quantification for ascorbic acid in human plasma was linear from 1–100 µg/mL. The inter- and intra-day precisions and accuracy were determined and the results were found to be within ±15%. This method was successfully applied to a human pharmacokinetic study of ascorbic acid as well as dehydroascorbic acid after oral administration of 4,000 mg vitamin C tablets to healthy Korean volunteers.
